Octagon Capital Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $8.59M | Hold |
|
|||||
|
2022
Q4 | $11.1M | Hold |
|
|||||
|
2022
Q3 | $4.02M | Sell |
|
|||||
|
2022
Q2 | $4.42M | Sell |
|
|||||
|
2022
Q1 | $23.7M | Buy |
|
|||||
|
2021
Q4 | $34M | Buy |
|
|||||
|
2021
Q3 | $22.4M | Hold |
|
|||||
|
2021
Q2 | $20M | Buy |
|
|||||
|
2021
Q1 | $16.4M | Buy |
|
|||||
|
2020
Q4 | $15.7M | Buy |
|